IGF-1, IGFBP-1 and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: Findings from the breast and prostate cancer cohort consortium (BPC3)
Alpa V. Patel
, Iona Cheng
, Ferderico Canzian
, Loïc Le Marchand
, Michael J. Thun
, Christine D. Berg
, Julie Buring
, Eugenia E. Calle
, Stephan Chanock
, Francoise Clavel-Chapelon
, David G. Cox
, Miren Dorronsoro
, Laure Dossus
, Christopher A. Halman
, Susan E. Hankinson
, Brian E. Henderson
, Robert Hoover
, David J. Hunter
, Rudolf Kaaks
, Laurence N. Kolonel
Peter Kraft, Jakob Linseisen, Elliv Lund, Jonas Manjer, Catherine McCarty, Petra H.M. Peeters, Malcolm C. Pike, Michael Pollak, Elio Riboli, Daniel O. Stram, Anne Tjonneland, Ruth C. Travis, Dimitrios Trichopoulos, Rosario Tumino, Meredith Yeager, Regina G. Ziegler, Heather Spencer-Feigelson
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'IGF-1, IGFBP-1 and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: Findings from the breast and prostate cancer cohort consortium (BPC3)'. Together they form a unique fingerprint.